SuperworthDelcath Systems EPS DCTH
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $0.01
- Latest quarter, Q2 FY26
- $0.07
- +0% on a year earlier
- Fiscal year 2025
- $0.07
Delcath Systems' earnings per share was $0.01 over the twelve months to Jun 30, 2026, down 80% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.07, up 0% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.07 | n/a |
| FY2024 | −$0.98 | n/a |
| FY2023 | −$2.98 | n/a |
| FY2022 | −$4.16 | n/a |
| FY2021 | −$3.63 | n/a |
| FY2020 | −$112.56 | −100% |
| FY2018 | $226100.00 | n/a |
| FY2016 | −$122231200000.00 | n/a |
| FY2015 | −$192080000000.00 | n/a |
| FY2014 | −$368480000000.00 | n/a |
| FY2013 | −$997640000000.00 | n/a |
| FY2012 | −$2791040000000.00 | n/a |
| FY2011 | −$2101120000000.00 | n/a |
| FY2010 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.07 | +0% | $0.01 | |
| Q1 FY26 | −$0.03 | −200% | $0.01 | |
| Q4 FY25 | −$0.05 | n/a | $0.07 | |
| Q3 FY25 | $0.02 | −67% | $0.01 | |
| Q2 FY25 | $0.07 | n/a | $0.05 | |
| Q1 FY25 | $0.03 | n/a | −$0.50 | |
| Q4 FY24 | −$0.11 | n/a | −$0.98 | |
| Q3 FY24 | $0.06 | n/a | −$1.36 | |
| Q2 FY24 | −$0.48 | n/a | −$2.56 | |
| Q1 FY24 | −$0.45 | n/a | −$2.66 | |
| Q4 FY23 | −$0.49 | n/a | −$2.98 | |
| Q3 FY23 | −$1.14 | n/a | −$3.35 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DCTHDelcath Systems | $0.01 | −80% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| MOVMovado | $1.80 | +137% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| PDEXPro DEX | $4.11 | +52% a year |
| BVSBioventus | $0.77 | |
| Peer median | $1.27 |
Where Delcath Systems ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Delcath Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.